Tagged: Press release

Genprex Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex™ Clinical Development Program

Newly manufactured plasmids will be used in clinical trials evaluating Oncoprex™ in combination with targeted therapies and immunotherapies

AUSTIN, Texas & CAMBRIDGE, Mass.— (August 6, 2019) — Genprex, Inc.